HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ashwani Kumar Selected Research

Membranous Glomerulonephritis (Membranous Nephropathy)

5/2024Clinical Characteristics and Outcomes of Neural Epidermal Growth Factor-like 1 Protein-Associated Membranous Nephropathy.
1/2023Complementary medicine and phospholipase A2 receptor (PLA2R)-related membranous nephropathy-fortuitous or causal?
1/2016PLA2R antibodies, glomerular PLA2R deposits and variations in PLA2R1 and HLA-DQA1 genes in primary membranous nephropathy in South Asians.
8/2015Antibodies to m-type phospholipase A2 receptor in children with idiopathic membranous nephropathy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ashwani Kumar Research Topics

Disease

27Neoplasms (Cancer)
04/2024 - 07/2008
26Infections
02/2024 - 06/2008
16Malaria
04/2024 - 07/2003
12Alzheimer Disease (Alzheimer's Disease)
08/2023 - 01/2013
9Breast Neoplasms (Breast Cancer)
01/2023 - 01/2015
8COVID-19
03/2023 - 01/2021
7Dengue (Dengue Fever)
04/2024 - 01/2021
7Virus Diseases (Viral Diseases)
02/2023 - 08/2016
7Tuberculosis (Tuberculoses)
07/2022 - 12/2011
7Falciparum Malaria (Plasmodium falciparum Malaria)
09/2015 - 07/2003
6Obesity
04/2024 - 01/2012
6Neurodegenerative Diseases (Neurodegenerative Disease)
11/2023 - 07/2015
6Sepsis (Septicemia)
11/2023 - 08/2008
5Hypoxia (Hypoxemia)
01/2021 - 07/2007
5Chronic Kidney Failure (Chronic Renal Failure)
06/2020 - 03/2015
4Membranous Glomerulonephritis (Membranous Nephropathy)
05/2024 - 08/2015
4Inflammation (Inflammations)
01/2024 - 08/2016
4Cardiovascular Diseases (Cardiovascular Disease)
01/2023 - 08/2020
4Proteinuria
01/2022 - 08/2018
3Filarial Elephantiasis (Lymphatic Filariasis)
02/2024 - 01/2022
3Type 2 Diabetes Mellitus (MODY)
01/2023 - 05/2020
3Pain (Aches)
07/2022 - 07/2017
3Body Weight (Weight, Body)
01/2022 - 12/2012
3Membranoproliferative Glomerulonephritis (Membranoproliferative Glomerulonephritis, Type II)
01/2021 - 03/2015
3Glomerulonephritis
01/2021 - 03/2015
3Hypertension (High Blood Pressure)
03/2015 - 07/2003
2Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal)
05/2024 - 07/2016
2Leishmaniasis
04/2024 - 12/2023
2Retinal Diseases
01/2024 - 01/2020
2Retinal Degeneration
01/2024 - 01/2023
2Bites and Stings (Sting)
12/2023 - 11/2021
2Disease Resistance
07/2023 - 11/2021
2Carcinoma (Carcinomatosis)
05/2023 - 01/2023
2Dysbiosis
01/2023 - 01/2023
2Cysts
01/2023 - 01/2021
2Autistic Disorder (Autism)
11/2022 - 12/2017
2Parkinson Disease (Parkinson's Disease)
11/2022 - 08/2020

Drug/Important Bio-Agent (IBA)

30Proteins (Proteins, Gene)FDA Link
05/2024 - 07/2003
11EnzymesIBA
11/2023 - 06/2008
7Biomarkers (Surrogate Marker)IBA
04/2024 - 03/2018
6CreatinineIBA
09/2023 - 08/2018
6VaccinesIBA
01/2023 - 05/2012
6Antimalarials (Antimalarial Agents)IBA
09/2015 - 07/2010
5Peptides (Polypeptides)IBA
12/2023 - 09/2014
4Retinaldehyde (Retinal)IBA
01/2024 - 01/2020
4Transcription Factors (Transcription Factor)IBA
07/2023 - 01/2019
4Antiviral Agents (Antivirals)IBA
02/2023 - 01/2018
4RNA Polymerase II (RNA Polymerase B)IBA
01/2023 - 01/2018
4AntibodiesIBA
09/2022 - 08/2015
4Anti-Bacterial Agents (Antibiotics)IBA
11/2021 - 01/2009
4Chloroquine (Aralen)FDA LinkGeneric
01/2016 - 07/2003
4artemisinin (artemisinine)IBA
09/2015 - 07/2010
4ArtesunateIBA
12/2013 - 07/2010
3AmylasesFDA Link
04/2024 - 01/2023
3Lipase (Acid Lipase)FDA Link
04/2024 - 01/2018
3Long Noncoding RNAIBA
04/2024 - 01/2020
3ChromatinIBA
04/2024 - 01/2020
3SilverIBA
03/2024 - 01/2021
3Albendazole (Albenza)FDA Link
02/2024 - 01/2022
3DNA (Deoxyribonucleic Acid)IBA
02/2024 - 02/2013
3Diethylcarbamazine (Hetrazan)FDA Link
02/2024 - 01/2022
3AcetylcholinesteraseIBA
01/2024 - 01/2013
3AntigensIBA
01/2024 - 12/2021
3Pyrethrins (Pyrethroids)FDA Link
10/2023 - 09/2015
3AntioxidantsIBA
09/2023 - 12/2011
3PhytochemicalsIBA
09/2023 - 07/2022
3Blood Glucose (Blood Sugar)IBA
04/2023 - 05/2020
3Phospholipase A2 ReceptorsIBA
01/2023 - 08/2015
3Serum AlbuminIBA
01/2022 - 08/2018
3Sirtuin 1IBA
11/2021 - 08/2016
3Amyloid (Amyloid Fibrils)IBA
11/2021 - 09/2014
3Phosphotransferases (Kinase)IBA
11/2021 - 07/2007
3Complement Factor H (Factor H)IBA
01/2021 - 03/2015
3Complement System Proteins (Complement)IBA
03/2019 - 12/2002
3SteroidsIBA
08/2018 - 07/2016
3ProteomeIBA
08/2017 - 01/2017
3pyrimethamine drug combination fanasil (Fansidar)FDA Link
01/2016 - 03/2004
3Mefloquine (Lariam)FDA LinkGeneric
12/2013 - 07/2010
2CopperIBA
04/2024 - 01/2021
2MicroRNAs (MicroRNA)IBA
04/2024 - 01/2021
2InsecticidesIBA
04/2024 - 09/2015
2Monoamine Oxidase (MAO)IBA
11/2023 - 01/2013
2Urea (Carbamide)FDA LinkGeneric
09/2023 - 10/2022
2QuercetinIBA
09/2023 - 01/2019
2tau Proteins (tau Protein)IBA
08/2023 - 02/2018
2Pregnenolone Carbonitrile (PCN)IBA
07/2023 - 01/2023
2Adenosine Triphosphate (ATP)IBA
07/2023 - 01/2020
2InterferonsIBA
02/2023 - 01/2023
2Hyaluronic Acid (Hyaluronan)IBA
01/2023 - 01/2023
2Heparin (Liquaemin)FDA LinkGeneric
01/2023 - 01/2023
2Sulfates (Sulfates, Inorganic)IBA
01/2023 - 01/2023
2Protein Isoforms (Isoforms)IBA
01/2023 - 01/2021
2Free RadicalsIBA
11/2022 - 05/2021
2Matrix Metalloproteinases (MMPs)IBA
11/2022 - 01/2021
2Metalloproteases (Metalloproteinases)IBA
11/2022 - 10/2019
2Estrogens (Estrogen)FDA Link
10/2022 - 06/2021

Therapy/Procedure

24Therapeutics
04/2024 - 07/2003
2Cholecystectomy
02/2024 - 09/2015
2Mass Drug Administration
01/2023 - 01/2022
2Complementary Therapies (Alternative Medicine)
01/2023 - 01/2012